In this study, two unique three-dimensional Cd(II)-based coordination polymers, [Cd3L12(H2O)4]∙(CH3CN)∙(H2O) (1) and [Cd3L22(H2O)2] (2), were successfully synthesized under solvothermal conditions. The organic linkers selected were two tricarboxylic acid ligands, H3L1 and H3L2 (H3L1 = 4,4′,4″-((benzene-1,3,5-tricarbonyl) tris(azanediyl)) tribenzoic acid, H3L2 = 4,4′,4″-(benzene-1,3,5-triyltris(azanediyl))tribenzoic acid). Furthermore, fluorescence performance tests of the complexes indicated that through coordination with the metal center and the semi-rigid triangular ligand, as well as the formation of a highly rigid network involving the framework and free solvent molecules in a hydrogen bond network, complexes 1 and 2 exhibited excellent blue fluorescence. Building upon this, given the poor biocompatibility of metal–organic frameworks (MOFs) as carriers, we employed hyaluronic acid (HA)/carboxymethyl chitosan (CMCS) hydrogel for encapsulation and paclitaxel loading. A novel paclitaxel drug delivery system, HA/CMCS-MOFs@paclitaxel, was developed, and the effects of the two systems on the expression of the cancer proliferation marker gene Ki-67 in OSCC cells (CAL27) were evaluated. Results demonstrated that the synthesized paclitaxel-loaded metal gel particles exhibited potent inhibitory activity against Ki-67, showcasing their potential as therapeutics for oral cancer.